Clinical trials: CYP3A4 Induction, open to volunteers
Healthy Volunteers
A Study to Assess the Potential CYP3A Induction Effect of Brensocatib on the Pharmacokinetics (PK) of Midazolam in Healthy Participants
The primary objective of this study is to assess the effect of multiple doses of brensocatib on the single dose PK of oral midazolam when coadministered in healthy male and female participants.
- Trial name
- NCT07859007
- Testing
- Brensocatib, Midazolam
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Insmed Incorporated